CME Accreditation

Joint CME accreditation provided by the University of Colorado School of Medicine

Meeting Evaluation forms
Your feedback is important to our CME accreditation requirements and to support ATA efforts to bring you high quality programming. Please complete the evaluation forms below.

CME Credits and Certificates
Please click here: www.prereg.net/2013/atas/ceu to claim your CME credits and print your CME certificate from the ATA Spring 2013 meeting. Please use five-digit number (XXXX-X) printed on your meeting badge without the dash along with your name to log into this website. Please remember to complete and submit the meeting evaluation forms above.

CME ACCREDITATION

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Colorado School of Medicine and the American Thyroid Association. The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 13.25AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

TARGET AUDIENCE
This meeting is designed for the community of endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, endocrine fellows and nurses, physician assistants and other health care professionals who wish to broaden and update their knowledge of the thyroid gland and its disorders. Clinical, Basic and Surgical Fellows will have a customized educational track to enhance their meeting experience.

EDUCATIONAL DESIGN
The ATA Spring Meeting will feature innovative talks on clinical topics, “meet-the professor” workshops, interactive sessions, state of the art information and unparalleled collegiality. Upon completion of this conference participants should be able to:

  • Determine and translate the latest basic and clinical research in thyroid hormone metabolism, transport, and action into management recommendations
  • Improve expertise in management of hypothyroid patients
  • Review the development of alternatives to the use of levothyroxine alone
  • Recognize the role of traditional thyroid hormone replacement therapy

CME NOTICE
As a sponsor accredited by the ACCME, the University of Colorado School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty participating in a sponsored activity are expected to disclose to the provider any relevant personal financial interest or other relationship involving themselves or their spouse/partner within the last 12 months with any proprietary entity producing health care goods or services (excluding nonprofit or government organizations) related to the content of the activity.

Consistent with the University of Colorado School of Medicine policy, faculty for this activity are expected to disclose any economic or other personal interests that create, or may be perceived as creating, a conflict related to the material discussed. This policy is intended to make you aware of faculty’s interests, so you may form your own judgments about such material. In addition, consistent with University of Colorado School of Medicine policy, faculty are expected to disclose to you at the beginning of their presentation(s) any product mentioned during their presentation that is not labeled for the use under discussion or is still investigational. This policy is intended to allow you to form your judgments about such material.